Breast Cancer Receptors as Therapeutic Targets:Structural Insights and Molecular Docking Approaches

Authors

  • Nehal Rami Department of Microbiology, Mehsana Urban Institute of Sciences, Faculty of Science, Ganpat University, Ganpat Vidyanagar-384012, Mehsana, Gujarat, India Author

DOI:

https://doi.org/10.67706/39s2rw47

Keywords:

Breast Cancer, Molecular Receptors, Molecular Docking, Next-generation therapeutics, Targeted Therapy

Abstract

Breast cancer is the second most common cancer world-wide and among the deadliest cancers for females too. Various alterations have various flesh and blood protein sign look gone oestrogen receptor-alpha (ERα), human skin enhancement factor receptor 2 (HER2), progesterone receptor (PR) and skin improvement factor receptor (EGFR), and these molecules donate much to the heterogeneity observed in breast tumours. Over the past years, therapies based on receptor targets have improved the outcome of the patients. However, there are threats of drug resistance and relapse that have jeopardised the efficacy in mainstream treatment and so alternative novel treatment strategies are in high demand. Different computational methods have proven to be extremely valuable for the rational design of breast cancer drug candidates which target these receptors. The current analysis centers on the use of molecular docking and virtual screening to create drugs. In receptor-specific drug discovery and design, this approach has achieved extremely high success. Another significant aspect that is highlighted here is the availability of the detailed 3D structures for these receptors in the PDB which allows one to run docking based approach for effective identification and optimization of inhibitors and modulators. In addition, important recent receptors with a verified role in breast cancer such as androgen receptor (AR), G protein-coupled estrogen receptor (GPER), CXCR4 and PD-L1 have shown very encouraging potential in clinical settings and represent a new wave of personalized medicine in breast cancer. The faster development of individualized and more efficient treatment strategies for breast cancer may occur due to this integration.

Published

27-10-2026